Which peptides have been studied in cognitive research?
-
KPVLys-Pro-Val
Three-amino-acid fragment of alpha-MSH, studied in cell and mouse models of inflammation. Not licensed in the UK. No human trial of KPV was found.
PreliminaryNot licensed in the UK -
Oxytocin
Natural hormone licensed in the UK for obstetric use; studied separately for social cognition, with mostly negative trial results.
LimitedLicensed for a different use -
SemaxACTH heptapeptide analog
Synthetic ACTH-derived peptide studied for brain function and stroke recovery. Not licensed in the UK; evidence is mainly rodent studies.
LimitedNot licensed in the UK
Best recorded finding for each peptide in this area
| Peptide | UK status | Finding | Study type | Evidence grade |
|---|---|---|---|---|
| KPV | Not licensed in the UK | Mouse brain-injury study | Animal | Preliminary |
| Oxytocin | Licensed for a different use | The 2005 trust game | Human trial | Limited |
| Semax | Not licensed in the UK | Acute ischaemic stroke trial | Human trial | Limited |
About this research area
"Cognitive Research" covers peptides studied for effects on brain function, including memory, neuroprotection, neurotrophic signalling and social cognition such as trust or emotional processing. Evidence in this category ranges from rodent gene-expression and neurotrophic-factor studies through to small human clinical trials, including stroke-recovery research and social-cognition studies using functional neuroimaging. As with every Research Area, classification here reflects a genuine line of published cognitive-science enquiry, not a validated cognitive or therapeutic effect.
10 sources in the library relate to this area. See them.
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.